DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Papatheodoridis GV, Idilman R, Dalekos GN. , et al.
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.
Hepatology 2017;
66 (05) 1444-1453
We do not assume any responsibility for the contents of the web pages of other providers.